This year, China has granted approval to 52 innovative medical device products, raising the cumulative total to 367. The National Medical Products Administration has implemented ten strategic measures, primarily aimed at bolstering key sectors like medical robotics, advanced medical imaging, AI-driven medical devices, and novel biomaterials. These initiatives are designed to comprehensively foster the research and development of high-end medical devices, while encouraging the debut of top-tier global products in China. The ultimate objective is to enhance public health through the introduction of more high-quality medical products.